ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Workshop Not “A Formality,” Baines Responds To Kopans

November 19, 1993

In Brief: Armitage Appointed to NCAB; UT Board Approves New Clinical Building for MDACC

May 19, 2000

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980

NCI Cooperative Group Clinical Trials Approved

November 27, 2009

NIH reauthorization to be topic of July 19 hearing.

July 15, 2005

Wynder, Doll, Hill Share Ochsner Award

September 23, 1988